WHO urges governments to protect young people from addiction to tobacco and nicotine products
Worldwide, at least 40 million children aged 13–15 use tobacco products, and young people’s use of e-cigarettes and nicotine pouches continues to rise. In advance of World No Tobacco Day – 31 May – the World Health Organization (WHO) urges governments around the world to protect a new generation from becoming addicted
MedScopeGlobal Editorial
May 29, 2026
Evidence-based clinical briefing
WHO urges governments to
Shrnutí
Worldwide, at least 40 million children aged 13–15 use tobacco products, and young people’s use of e-cigarettes and nicotine pouches continues to rise. In advance of World No Tobacco Day – 31 May – the World Health Organization (WHO) urges governments around the world to protect a new generation from becoming addicted
Klinický význam
Tento článek byl automaticky zpracován ze zdroje WHO News. Pro plné redakční zpracování nastavte OPENAI_API_KEY.
Zdroj
MedScopeGlobal — ověřte vůči primární literatuře před klinickým použitím.
Related coverage
Evidence-based summary
Diagnostika a screening u
Všeobecné lékařství
Diagnostika a screening u nejčastějších symptomů
Přehled nejběžnějších diagnostických kroků u symptomů, které se opakovaně objevují v ambulanci.
Doporučený obsah
Články
- Mapping the intellectual structure and emerging trends of neurophobia research in health professions education
- Mapping the intellectual structure and emerging trends of neurophobia research in health professions education
- Synergistic Renoprotective Effects of Moderate-Intensity Resistance Training and Vitamin D Supplementation on a Type 2 Diabetic Nephropathy Rat Model
- Diagnostika a screening u nejčastějších symptomů
Studie
- RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings
- Upskilling Rheumatology Occupational Therapists in Work Rehabilitation: An Evaluation of a Job Retention Vocational Rehabilitation Training Course (the Workwell Trial)
- Satisfaction with telemedicine versus in-person visits in rheumatology: a noninferiority randomised controlled trial